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SUMMARY
Mathematical models are potentially useful tools to aid in the design of control
programmes for parasitic diseases. In this paper, a fully age structured
epidemiological model of human schistosomiasis is developed and parameterized,
and used to predict trends in infection prevalence, intensity and prevalence of
heavy infections over age and time during several rounds of mass and age targeted
treatment. The model is validated against data from a Schistosoma mansoni
control programme in Kenya.
INTRODUCTION
Schistosomiasis is a major parasitic disease in many areas in the developing
world. Although rarely causing mortality, the morbidity caused by this disease
can inflict a heavy health burden on high-prevalence communities. The highest
intensity of infection is usually observed in children but chronic consequences of
infection may last into adulthood. At present, a cost-effective method of
controlling the morbidity caused by schistosomiasis is chemotherapy on a
community level, especially since the development of the drug, praziquantel,
which can be used as a single oral dose and against all the main species of
schistosomes. For designing community level control programmes, mathematical
modelling of transmission dynamics has proved to be a useful tool in many human
infections [1]. and this paper explores the development of a model to assist the
design of schistosomiasis control programmes.
Transmission models of schistosomiasis have been in existence since the 1960s
[2. 3]. These models have used the indirect life-cycle of schistosomes as the basis
of the model with the explicit modelling of transmission between man and snails
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(the intermediate hosts) and between snails and man. These models can be used
to assess different types of control strategies such as chemotherapy and snail
control. A different approach has generally been used to model intestinal
nematode dynamics. Since the timescale of the free-living stages is much shorter
than that of the mature worm in the human host, the free-living stages are
assumed to be at equilibrium and the system is modelled with respect to the
mature worm population only [1,4—8]. This reduction in model complexity by
bypassing the intermediate life stages is also applicable to schistosomes since the
timescale of snail infection (a few weeks) is much shorter than that of human
infection (several years). This simplifies the analysis since fewer processes need to
be characterized. This is the approach taken in this paper.
The framework explored here is based on an age structured model previously
developed for intestinal helminth dynamics [8], In this model there are two host
groups, representing adults and children with different infection and con-
tamination rates. This age group structure can be used to assess the consequences
of child targeted chemotherapy programmes which can be subjected to cost-
effectiveness analysis [9].
In this paper we adapt this framework to model human schistosomiasis. The
model is expanded to become a fully age-structured partial differential equation
model. This is necessary because schistosomes have a much longer lifespan than
intestinal helminths and therefore the movement of humans between age groups
has a more significant epidemiological effect. Age dependent functions of infection
and contamination, as well as the demographic age structure, are also included.
Unlike the case with intestinal nematodes, there is no simple way to measure
human worm burden for schistosomiasis and all available field results report
intensity in terms of egg counts. The model was therefore modified to allow input
and output in terms of egg counts. The results of this model are compared with
field data from Schistosoma mansoni control programmes.
CONCEPTUAL FRAME WO R K
The schistosomiasis model is developed from the age structured intestinal
helminth model described in Chan and colleagues [8]. The main development is
from a model with two constant host age groups to a continuous partial
differential equation model in which infection intensity is modelled as a continuous
function of age and time. There is assumed to be a reduction in the rate of infection
with increased level of present infection (analogous in effect to concomitant
immunity) and this provides the density dependent feedback in the system.
Overall rates of infection and contamination are assumed to be functions of age.
and simple empirical functions which peak in the childhood or teenage years are
used to simulate these. Data on the demographic age distribution are also
incorporated into the framework as the differential contribution of each age group
to the transmission of the disease is important.
Data input and output from the model are in terms of mean egg count, either
as an arithmetic or geometric mean, and translated to mean worm burden using
statistical methods (see section on estimation of parameters). Other outputs from
the model are infection prevalence and an estimate of the risk of morbidity due to
high levels of current infection (for example, an estimate of the number of
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individuals excreting more than 100 epg or eggs per gram of faeces). Age targeted
chemotherapy is simulated as an instantaneous reduction of infection intensity in
the targeted age groups determined by the coverage and drug efficacy. There will
be two effects of treatment, the reduction of infection intensity in the treated age
groups due to treatment and the reduction in the other age groups due to the
overall reduction in transmission [7].
MODEL DEVELOPMENT
A fully age structured partial differential equation model is developed from the
two age group model described in Chan and colleagues [8]. It is similar in structure
to an intestinal helminth model published by Anderson and May [5, 6] but also
includes heterogeneous contact and contamination rates by age. The rate of
change of mean worm burden (M) over age (a) and time (t) is given as:
...(1)
+ A(M)
where [i is the mortality rate of the mature parasite. The quantity A(a, t) includes
the processes of production of infective stages, infective contact and establishment
of mature parasites as well as any density dependent processes operating in the
transmission cycle. Anderson and May's model assumed that the rate of contact
with infective stages is independent of age. However, epidemiological field studies
suggest that the contact rate with infection is strongly dependent on age [10, 11].
In this model, this age-dependent infection rate is modelled using the following
(unsealed) function p(a):
p(a) = a e( ' ', (2)
which gives a peak at the age l/fi which is typically in the child age classes.
As well as age-dependent contact rates, the model also includes age-dependent
contamination rates which represent the rates at which individuals of different
ages contaminate the environment with infective stages. This is represented by a
similar function K(a):
K(a) = a*S-9a\ (3)
which gives a peak at age 1/6 which is also typically in the child age classes.
Given a demographic age distribution of n(a), the age-dependent force of
infection can then be given as:
fiRop(a)f(M(a,t)) n(a) K(a)M(a,t)da
Ma. t) = ; ^ , (4)
n(a) K(<J) p(a) da
where f(M(a, t)) is a density dependent worm establishment function and Ro is the
basic reproductive number. Worm establishment is assumed to be reduced when
the current worm burden is high, which is intended to simulate the action of
concomitant immunity which provides the density dependent mechanism in this
model. It is assumed that the reduction in establishment in a host with n worms
is given by e~yn. The distribution of worms between hosts at any time is given by
a negative binomial distribution with meanM and an aggregation parameter k(M)
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Time (years)
Fig. 1. An example of a simulation comparing the results of the model in Chan and
colleagues [8], using parameters for Ascaris lumbricoides (large roundworm). which
simulates the changes in worm burden distribution after treatment (solid lines) with
a simplified model in which the worm burden distribution is kept constant (dashed
lines). The changes in worm burden over time are shown for adults (light line) and
children (heavy line) separately. Children are treated every year for 5 years. The close
correspondence between the two models justifies the use of the simpler framework in
the schistosomiasis model.
which increases linearly with the mean worm burden. f(M(a.t)) can therefore be
given as [1]: , _ \-<*Wf)+i)
(5)
The approximation of a fixed negative binomial is shown to give very close results
to more complex models of parasite distributions which include explicit changes
in worm distributions as a result of treatment [1. 7. 8]. An example of the
correspondence between a model with a fixed distribution and the complex model
described in Chan and colleagues [8] is shown in Fig. 1. Since the more complex
model would be very difficult to implement for a partial differential equation
model, and the results of the two approaches are similar, there is good justification
for using the simpler method. Ro has to exceed unity for the infection to remain
endemic. The derivation of the equations of this model and the basic definition of
Ro are discussed in more detail in the appendix.
The model is run by assuming that the population parasite distribution is
initially at equilibrium. Treatment by chemotherapy perturbs this equilibrium.
The equilibrium age distribution of mean worm burden (M*(a)) can be calculated
by solving the following ordinary differential equation:
dM*(a)
da = A(a,t)-fiM. (6)
The details of the procedure used to set up the equilibrium age-intensity
distribution are discussed in the appendix.
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Treatment by chemotherapy is modelled as an instantaneous reduction in the
mean worm burden. Treatment is administered in an age targeted manner but
individuals in the treated age groups are selected for treatment at random. The
treated age groups are treated with a coverage (c) with a drug of efficacy (E). The
instantaneous reduction in mean worm burden is therefore given by:
M(a,t)^(l-cE)M(a,t). (7)
Since data on worm burden for schistosomiasis during the course of a control
programme are not available, the input and output of the model are given in terms
of mean egg count. It is assumed that there is a constant average number of eggs
produced per worm (mating probabilities are not taken into account) given by et.
Data on mean egg counts are generally given as either arithmetic or geometric
means. The arithmetic mean (EA) is related to the mean worm burden by:
EA = e{M. (8)
The geometric mean (EG) is calculated from the assumed negative binomial
distribution of worms. If the probability of harbouring x worms is px, the
geometric mean is given as:
px\n(x+l))-l. (9)
The model also calculates the prevalence of infection and the proportion of people
above a threshold egg count (an estimate of morbidity) from the negative binomial
distribution.
A computer program to implement the model was written in FORTRAN.77 and
run on a SUN workstation. The mean worm burden is calculated using a numerical
finite difference method (Euler type method). This method is shown to be accurate
enough for this model using a time step of 0-05 years.
ESTIMATION OF MODEL PARAMETERS
The central objective of this paper is not the estimation of reliable values for the
model parameters but the development of a modelling framework for schisto-
somiasis. Therefore where estimates of parameter values exist, these were used
and only parameters for which no values are published were estimated.
There are estimated values for the basic epidemiological parameters of all the
species of schistosomes and in general the values published in Anderson and May
[1] are used. This includes the worm lifespan (4 years) and the basic reproductive
number (in the range 1-4).
Measures of worm burdens are available from a few autopsy studies [12].
However, these data are very few in number and do not represent a random
sample from a community. In this study worm burden and worm burden
distribution were estimated using a statistical method which analyses paired data
on prevalence and mean egg count. A dataset for <S. mansoni was obtained from
previously published analyses [13].
Initially a model developed originally by Booth [14] for Trichuris trichiura
infections was used. This model estimates an appropriate form for the function of
the negative binomial parameter k against mean worm burden and a form for the
change in egg output per female with worm burden (the model includes the effect
of mating probability). The results of the analysis for the S. mansoni data are
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Table 1. Analysis of prevalence-intensity data for S. mansoni
k function e, function Maximum likelihood
Constant: 0-2385 Constant: 7-3508 -7981-78
Linear: 01453 + 000071/ Constant: 4-0938 -794339
Constant: 0-2359 Exponential: 6-9665e" 0001/ - 7980-54
Linear: 0-1405 + 0-0003M Exponential: 2-8996e-°0004/ -7946-89
Constant: 0-2365 Power: 6-9339/-00001 -798180
Linear: 01447 +0-0007J/ Power: 40229/~00001 -794340
This table shows the fitted values for the aggregation parameter (k) and the egg output per
female worm (et). The maximum liklihood value is shown for different assumed functional
forms; the higher this value, the better the fit. The k functions are functions of the worm burden
M whereas the fecundity function is a function of the number of female worms. / . A sex ratio
of 1 is assumed.
Table 2. Default parameter set used for all simulations
= 1-4
Parameter
Concomitant immunity
Maximum human age
Peak age for contamination
Timestep
Maximum worm burden
Demographic constants
Aggregation parameter (intercept)
Aggregation parameter (slope)
epg per worm
Worm lifespan
Symbol (units)
r
A (years)
I/O
Years
be-""
K
e.
1/u
\ alue
0001
80
8
0-05
2000
b = 00455
0132
0002
5-26
4
Source
Adjusted to give Ko
Estimated
Estimated
Present analysis
Cheever [12]
World Bank data
Present analysis
Present analysis
Present analysis
Anderson and Mav 11]
shown in Table 1. These results suggest that there is no appreciable density
dependence in fecundity and that the most appropriate function for k is a linear
function. It is interesting to note the appropriate functional forms are the same as
obtained by Booth [14] for T. trichiura. These were the forms of the functions
used.
The model was then refitted without taking into account mating probability
(since it is not part of the dynamic model) or density dependent fecundity and
using a linear function for k. This yields three parameters, an intercept and slope
for the k function and the mean egg output per worm (er). These are shown in Table
2 (these values are slightly different from those in Table 1 because of the different
assumptions). A comparison of the observed data and the fitted model is shown in
Fig. 2a.
The transmission model requires the input of the demographic age distribution
of the human population. For the purposes of this analysis it was assumed that the
age distribution is constant through time and is the current observed age
distribution. Data on current demographic distributions in different regions of the
world were obtained from the World Bank Global Burden of Disease' study. A
good empirical fit was found by using an exponential function for Sub-Saharan
Africa and the Middle East and using parts of the Normal curve for Latin
America, China, India and South East Asia. Note that these are purely descriptive
functions and do not model processes of birth and death. The data used in this
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Fig. -'. Fitted functional forms used as input to the schistosomiasis model, (a) Tlie
relationship between prevalence and mean egg intensity (ari thmetic mean). The line
shows the fitted function and the da ta points are published in [13). Parameter values
are uiven in Table l\ 1,1)) Fitted generalized demographic function for Sub-Kaharan
Africa showing the percentage of individuals in 5-year age bands . Data are from the
World Bank (bars) and the fitted function used is exponential (lines) with parameters
given in Table 2.
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Table 3. Parameters used for validation of data from Kenyan S. mansoni
control programmes
Parameter
Peak age intensity
Peak mean epg (arithmetic)
Treatment schedule
Coverage
Drug efficacy
Treated ages
Symbol/units
epg
c
e
Area A
20
45
1981: children
1983: all
1985: all
1981: 50%
1983 & 1985: 93%
99%
1981: 7-18
1983 & 1985: all
Area
15
234
1985
99%
99%
7-18
Values obtained from Butterworth and colleages [15] and Sturrock and colleagues [16]. See
text for other details of programmes.
paper are from Africa and the exponential model used to simulate the age
distribution is shown in Fig. 26.
The default set of epidemiological parameters used is shown in Table 2.
VALIDATION OF MODEL FOR S. MANSONI
The model was validated for S. mansoni using data collected by Butterworth
and colleagues [15] in Kenya. In this project, different localities were given
different programmes of treatment with a view to comparing the outcomes of
different control strategies. Infection prevalence, intensity (measured as geometric
mean epg), and prevalence of infections over 100 epg were measured, all of which
can be directly output from the model. Two treatment programmes are of
particular interest in the context of the model; the area designated Area A in
which all individuals were treated and Area S where only school-children were
treated. The treatment parameters and initial epidemiological conditions are
taken from the study and are shown in Table 3. Other parameters are as in Table
2. Note that the age intensity profile for the model is generated from the
generalized function for age dependent exposure rather than using the actual age
intensity profile observed in the study.
The treatment history of Area A is somewhat complicated and had to be
simulated to give a sensible comparison between the model and data. A number
of children had previously been treated in 1981 and the pretreatment intensity
had to be obtained from an earlier publication [16]. This child targeted treatment
had to be simulated before also simulating the mass treatments in 1983 and 1985.
In Area S, school-children between the ages of approximately 7 and 18 years were
treated in 1985.
The predicted and observed results are shown together in Fig. 3a-/. The
predicted and observed intensity of infection over age and time for Area A are
shown in Fig. 3a and b respectively. The model correctly predicts that there is
hardly any reinfection over the time period of the programme (4 years after the
last mass treatment). In fact, infection has been reduced to and maintained at
negligible levels after two mass treatments.
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In Area S, where children only were treated, a greater degree of reinfection
occurs (Fig. Sc-d). The model correctly predicts this but slightly overestimates the
rate of reinfection particularly in the older age classes. This overestimation
appears to reflect the unusually severe initial age convexity of intensity in this
population (compare 1981 data for Fig. 36 with 1984 data for Fig. 3d). The
predicted and observed prevalence of heavy infection are shown in Fig. 3e-/and
again there is reasonable correspondence between model and data.
The underlying distributional assumptions of the model can also be tested with
these data. Fig. 4 shows the prevalence of heavy infection (> 100 epg) plotted
against the overall prevalence of infection (Fig. 4a), prevalence plotted against the
mean egg count (Fig. 4b) and prevalence of heavy infection plotted against the
mean egg count (Fig. 4c). The data points include data from different age groups
and years, pre and post treatment and from Area A and Area S. Several points are
to be noted from these graphs. Firstly, the data points clearly show a consistent
relationship between the parameters plotted, which demonstrates the feasibility of
using a common distributional form for all ages and pre and post treatment.
Secondly, the data and model correspond very closely, which gives extra support
for the predictive abilities of the model. Note that these data are not the same as
the data in Fig. 2a and this therefore is an independent test of the model. Thirdly,
a small, but systematic, discrepancy is observed between the data and model and
is probably due to the distribution of worms (measured by the function k(M)) in
this locality being slightly different from the global average values used in the
model. This underlines the importance of using locality specific parameter values
(from pre-treatment data) for predictions, while also showing that more global
data do usefully predict the overall trends.
With respect to using the model as a tool for assessing the benefits of treatment,
an important test is whether the model can correctly assess the relative benefits
of different programmes of treatments. The actual and predicted benefits of the
programmes are shown in Table 4. The model estimates are sufficiently close to the
actual benefits to warrant using the model to compare the potential suitability of
different control programmes.
.SIMULATION OF TREATMENT PROGRAMMES
The model was used to simulate different control scenarios in order to illustrate
the potential community impact of long-term treatment programmes. Typical
control strategies are simulated but the time scale chosen is deliberately long (50
years, comparable to human lifespan) to include ageing related effects. Treatment
is carried out for 20 years following by reinfection for 30 years. Treatment
parameters are given in Table 5. Arithmetic mean egg count over age and time is
plotted for the different control programmes in Fig. 5. For modelling purposes, the
arithmetic mean is considered more appropriate than the geometric mean because
it is a direct measure of total population size.
Fig. 5a (Control 1) shows a programme with treatment of children aged 7-18
years every 2 years. The simulation shows a decrease in the intensity of infection
over the 20 years of treatment and a slow rate of reinfection thereafter. The
regular treatment of the most heavily infected age group sustained over a long
period results in the virtual elimination of the worm population and therefore the
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1981
1981
1984
0-4 5-1 9-1
"13-2021-40
1988
>40
Fig. 3. Model val idat ion predicted and observed results. Observed results are from a
S. mansoni control p rogramme in K e n y a published in But te rwor th and colleagues [15].
In Area A mass t r ea tmen t occurred whereas in Area S t r ea tment of school-children
occurred, see text for details. Pa rame te r values are given in Tables 2 and 3. Results
are p lot ted bv age group and year as follows, (a) Area A. predicted results, geometric
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(d)
1984
1984
1984
0-4
>40
mean egg intensity, (b) Area A. observed results, geometric mean egg intensity, (c)
Area S. predicted results, geometric mean egg intensity, (d) Area S. observed results,
geometric mean egg intensity, (e) Area S. predicted results, prevalence of infections
more than 100 epg. (/) Area >S. observed results, prevalence of infections more than
100 epg.
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Fig. 4. Comparison of observed and predicted parasite distributions. Squares show the
Butterworth and colleagues [15] dataset, solid line shows the model prediction, (a)
Prevalence of infections more than 100 epg against the overall prevalence of infection.
(b) Prevalence of infection against geometric mean egg intensity, (r) Prevalence of
infections more than 100 epg against geometric mean egg intensity.
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Table 4. Model validation predicted and observed benefits
Area and measure Predicted benefit Observed benefit
Area A. intensity 1679 14-71
Area A. prevalence 0-255 0-207
Area A. > 100 epg 0-165 0-118
Area S. intensity 53-47 45-56
Area 8, prevalence 0-088 0-116
Area H. > 100 epg 0-114 0-128
Benefit measures show average reduction in intensity (geometric mean epg), infection
prevalence and prevalence of > 100 epg per year over the duration of the simulation, averaged
over all ages, achieved as a result of treatment. Prevalence of infection and infection > 100 epg
are quoted as proportions.
Table 5. Parameters used in simulated control programmes
Parameter Symbol/units Value
Peak age intensity l/{l + l/(i 15
Peak mean epg (arithmetic) epg 500
Treatment schedule Start year 1;
finish year 21
Coverage c Children 80%;
adults 50%
Drug efficacy e, 95%
Treated ages Child: 7-18;
all: 0-80
rate of infection is very slow. Note that those individuals treated during the
programme are not heavily reinfected since they would be older in the reinfection
period and thus experience lower rates of exposure. Since all individuals are aging
over time in the model, those getting reinfected will be of younger cohorts than
those originally treated.
Fig. 56 (Control 2) shows the treatment of children every 4 years. This longer
interval of treatment allows more reinfection between treatments and therefore
transmission is not reduced to very low levels. Consequently, the rate of
reinfection after the treatment stops is significantly higher than in the previous
example.
Fig. 5f (Control 3) shows mass treatment of all ages every 4 years. The coverage
levels are 80% for school-age children (7-18 years) and 50% for others. The
sustained cycles of mass treatment show reduction of infection to very low levels
with virtually no reinfection over 50 years.
Fig. 5rf (Control 4) shows one mass treatment followed by child targeted
treatment every 4 years. The initial mass treatment is thought to bring down the
level of transmission at the beginning of the programme. The long-term results of
this strategy, however, are not very different from the 4-yearly treatment of
children alone (Fig. 56).
The consequences of these control programmes are best assessed by comparing
the community benefits (Table 6). These essentially measure the average reduction
in infection intensity over the 50 years of the programme [7-9]. Note that these
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(a) Age (years) , n 10
30 '
10 Time (years)
50 40 50
500
10
40
50 Age (years)
20
Time (years) 30
10 10 Time (years)20 30 40 50
500
10
20
Time (years)
Fig. 5. Simulated control programmes. The graphs show arithmetic mean egg count
plotted over age and time. Treatment programmes are initiated in year 1 and finish in
year 21. 'Children' refers to individuals in between the ages of 7 and 18. See Tables 2
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10
Time (years)
20 30 40 50
500
Age (years)
10
20
Time (years) 30 40
(d)
500
Age (years)
 9f) 10
70
Time (years)
40 50
500
Age (years)
10
Time (years)
and 5 for parameter values, (a) Treatment of children every 2 years. (6) Treatment of
children every 4 years, (r) Mass treatment every 4 years, (d) Initial mass treatment
then treatment of children everv 4 vears.
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Table 6. Benefits for simulated control programmes
Programme Absolute benefit Relative benefit
1:
2:
3:
4:
Children every 2 years
Children every 4 years
Mass every 4 years
Initial mass then children 4 yearly
170
138
183
153
0-81
0-66
0-87
0-73
Benefit measures show average reduction in arithmetic mean epg per year over 50 years
averaged over all ages. Absolute benefit is the absolute reduction in intensity relative to no
control. Relative benefit is this reduction as a proportion of the mean intensity with no control.
are not directly comparable to those in the previous section since these are
measured in terms of arithmetic mean. Compared with the least intensive
treatment programme (child treatment every 4 years, Control 2), mass treatment
shows the highest increase in benefit (Control 3). This reflects the significant
amount of infection in other age groups, especially young adults. However, mass
treatment may be expensive to carry out and may achieve low coverage. Two-
yearly treatment of children (Control 1) also shows a high benefit. Although
requiring more interventions, this may be beneficial when other health
programmes at similar intervals may be offered to school children [17].
This exercise is intended to be illustrative of the use of the model for comparing
different control strategies. The quantitative results will clearly depend on the
initial parameter values, and the outcomes illustrated here are likely to be
parameter specific.
DISCUSSION
In this paper, a model of schistosomiasis transmission has been developed using
concepts from two earlier published models, those of Chan and colleagues [8] and
Anderson and May [5]. Unlike the earlier Chan and colleagues model, age structure
is explicitly simulated allowing individuals to age over time. This is necessary
when modelling long-lived parasite species where the lifespan of the worm is
comparable to the maturation time of the host. The shape of the age-intensity
profile can also be taken into account and treatment can be targeted at specific
ages. The Anderson and May [5] model has a full age structure but does not take
into account age related changes in contact with infection. The present model can
give a much more realistic description of community treatment programmes
because the greatest intensity of infection is assumed to be in the children which
is the generally observed pattern. The drawback of our more complex model is
that more parameters need to be estimated. In this paper, this was made as simple
as possible by using single parameter functions for the age related functions of
exposure and contamination and published data for the demographic age
distribution. Although this may not be a very accurate method, the levels of
uncertainty in other areas of the model do not warrant greater accuracy at
present.
The model predicted the observed trends in infection status over several years
after treatment very well given the likely magnitudes of experimental error. These
results give support for the predictive value of the model. Analysis of the predicted
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and observed benefits of treatment programmes indicate the potential ability of
the model to aid policy decisions. The model was tested over a timescale of
approximately 10 years. Care must be taken, however, when using this model to
make longer-term predictions. This is because over longer timescales effects of
acquired immunity (not included in the model) may have a marked impact.
Furthermore, neither the local transmission environment nor the population
demography can be assumed to be constant over such long timescales. The
simulated treatment programmes show perhaps less reinfection than one would
imagine. These simulations can be viewed as similar to a 'projection' of the
Butterworth and colleagues [15] control programmes continued for 20 years. Since
the parameters used in the two analyses were similar, the low amount of
reinfection is actually an extrapolation of the Butterworth and colleagues results.
Better understanding in three central areas of uncertainty in our understanding
of schistosome biology would greatly improve the predictive value of the model.
The first of these is the mechanism and strength of density dependence. The
marked stability of endemic helminth infections in human communities implies
that feedback processes must be operating but the nature of these is still unclear.
The evidence for density dependent fecundity is inconclusive [18-20] and the
analysis in the current paper found no evidence for it. Limited evidence does exist
for the action of concomitant immunity in human schistosomiasis [21] and mouse
models [22]. In this paper, density dependence is assumed to operate on
establishment. The strength of this mechanism, however, cannot be directly
measured in human experiments and in the model the value of this parameter is
fitted by assuming a value for the basic reproductive manner (assumed to be about
2)[7.8j.
The second central problem is the impossibility of knowing the true worm
burden for schistosome infections. The statistical method used [14] has low
discriminatory power due to the relatively large number of parameters estimated
and there are no data available for validating the results. This is in contrast to the
case for Trichuris trichiura. for which this model was originally developed since
there are limited anthelmintic expulsion data for this species. The inability to
estimate worm burden has important implications for estimating the basic
reproductive number. The only partial solution to this problem is to analyse more
datasets using the statistical method and ascertain whether there is a consistency
in the results. Data from autopsy or animal studies can also be consulted [12, 23].
The third area of uncertainty is in the basic epidemiological parameters for
schistosomes. The most often quoted values are 1-4 for the basic reproductive
number and 4 years for the worm lifespan [1] and these values are used here.
However, Woolhouse. Hasibeder and Chandiwana (unpublished observations)
calculated higher values (4-16) for the basic reproductive number by taking into
account acquired immunity and heterogeneity in exposure and contamination.
Also, recent analysis of the worm lifespan suggests a longer lifespan of
approximately 8 years (Fulford and colleagues, unpublished observations).
The uncertainty in the values of many of the parameters in the model indicates
that it will be important to carry out sensitivity analysis on the results of the
model. More sophisticated entry of the initial conditions (such as including
intensity, prevalence and water contact for all age groups rather than just the
peak intensity) would make better use of the data on infection status in a
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community and will lead to better predictions. Likewise, better estimates of the
parameter values will improve the usefulness of the model.
The public health significance of schistosomiasis includes chronic effects of
infection that develop over many years. Measures of morbidity such as prevalence
of hepatomegaly are monitored in some control programmes [15]. Such effects are
now being incorporated into a morbidity model in a continuation of the current
project. Acquired immunity may also have implications for the predictions of the
model [24] which can also be incorporated into the framework.
The main improvements of the current model over earlier versions are the
incorporation of age related patterns of transmission and infection and the ability
to compare the results directly with field data. Comparison between the model and
field data demonstrates a convincing ability to predict observed patterns. Such
a framework can be very useful in planning control interventions under a wide
variety of conditions. The framework lays down the foundation on which further
refinements can be made leading to the development of a potentially powerful
analytical tool to aid public health decision making.
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APPENDIX
Notes on the derivation of model equations
By taking into account the pool of 'free-living' infective stages and setting the
number of these to be always at equilibrium (L*), as described in the model
of Chan and colleagues [8], the force of infection by age can be written as
k(a)f(M,a.t)L* which can be represented as:
k(a)f(M(a,t)) n{a)A(a)M(a.t)da
\{a,t)= h . (Al)
fiL+ k(a)n(a)da
where the functions k(a) and A(a) are the absolute values of the age dependent
contact rate and contamination functions respectively and fiL is the infective stage
mortality rate.
For a randomly mixing population, the basic reproductive number can be given
as [8]:
n(a)A(a)k(a)da
:A 2)
k(a) n(a) da
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268800058453
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 20:58:38, subject to the Cambridge Core terms of use, available at
Schistosomiasis transmission model 343
By substituting Ro into equation (10) and rescaling the contact and contamination
functions using relative (p{a) and K(U) respectively) instead of absolute values,
equation (4) can be obtained.
Notes on calculation of the equilibrium age-intensity distribution
The initial epidemiological conditions are set up by inputting the age of peak
intensity (ap) and the intensity at this peak (mp). To calculate the equilibrium
worm burden distribution, it is assumed that the age of peak intensity is the sum
of the age of peak contact (///?) and the worm lifespan (l/fi) which is a very good
approximation, from which:
/? = —^—. (A3)
fiap - 1
Using this definition, an intermediate scaling factor (a) is calculated (by taking the
derivative of equation (6) as zero at the peak) which allows the calculation of the
equilibrium age intensity curve as follows:
a =
 e~^
apf(m )
dM*(a)
da = aa e-'
iaf(M{a))-/jM. (A 5)
Equation (14) is solved numerically.
The basic reproductive number (i?0) can then be evaluated, using the known
parameters, as:
r
a. n(a) K(a) p(a) da
Ro = —U . (A 6)
n(a)K(a)M*(a)da
The integrations are performed numerically using NAG subroutines [25].
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